Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine
- PMID: 12460249
- DOI: 10.1046/j.1528-1157.2002.13002.x
Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine
Abstract
Purpose: To study the markers of bone turnover in epilepsy patients in the different stages of the pubertal growth before and after the beginning of carbamazepine (CBZ) monotherapy.
Methods: We have investigated bone turnover in 60 epilepsy patients treated with CBZ. They were stratified according to pubertal stage and compared with a control group of 60 sex- and age-matched healthy children.
Results: After 2 years of therapy, we found higher values of the serum markers of bone formation [bone alkaline phosphatase (bone ALP), osteocalcin (OC), carboxy-terminal propeptide of type I procollagen (PICP), amino-terminal propeptide of type III procollagen (PIIINP)], and of bone resorption [carboxy-terminal telopeptide of type I collagen (ICTP) and the urinary cross-linked N-telopeptides of type I collagen (NTX)] in patients than in control subjects, in presence of a normal vitamin D metabolism.
Conclusions: CBZ induces an increase of bone formation and of bone resorption that seems to be independent of the pubertal stage.
Comment in
-
Abnormal ALP isoenzyme in children with epilepsy treated with carbamazepine.Epilepsia. 2003 Aug;44(8):1128; author reply 1129. doi: 10.1046/j.1528-1157.2003.15603.x. Epilepsia. 2003. PMID: 12887450 No abstract available.
Comment on
-
Bone health in epilepsy.Epilepsia. 2002 Dec;43(12):1453-4. doi: 10.1046/j.1528-1157.2002.48102.x. Epilepsia. 2002. PMID: 12460244 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
